NEWS & EVENTS

Recent Publication in Mammalian Genomics

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

LJI and Charles River Laboratories to Collaborate on COVID-19 Research

GemPharmatech US Launches New Website

GemPharmatech Presents Humanized Mouse Models to Support Bispecific Antibody and COVID-19 Preclinic Development at Biologics UK Oxford Global Conference

GemPharmatech and UC Davis Sign Agreement to Distribute Mouse Models in the US to Better Serve US Academic and Pre-Clinical R&D Communities

SARS-COV-2 MPRO Inhibitors With Antiviral Activity In A Transgenic Mouse Model

GemPharmatech Co., Ltd. Opens New Operations In United States To House More Than 6000 Research Mouse Models

GemPharmatech and Setsuro Tech Announce Distributor Agreement to Support Japanese Biomedical Research Community

GemPharmatech, a global leader in genetically engineered mouse models and preclinical research services, is proud to announce the establishment of a distributor agreement with Setsuro Tech Inc., a leading gene editing service provider based in Tokushima. This agreement marks a significant step by GemPharmatech towards serving the needs of Japan’s biomedical research community more closely and effectively.